What is the global market size of Precision Diagnostics Market?

Precision Diagnostics Market size was valued at USD 60.35 billion in 2021 and is poised to grow from USD 68.07 billion in 2022 to USD 201.27 billion by 2030, growing at a CAGR of 12.6% in the forecast period (2023-2030).

Who are the key vendors in the Global Precision Diagnostics Market?

New product launches, partnerships and investing in research & development have been a key business strategy for market. The global precision diagnostics market is fairly concentrated, with a few big and medium-sized market participants accounting for a large portion of market revenue. 'Abbott Laboratories', 'F. Hoffmann-La Roche Ltd.', 'Siemens Healthineers AG', 'Thermo Fisher Scientific Inc.', 'bioMérieux SA', 'Becton, Dickinson and Company', 'Danaher Corporation', 'QIAGEN N.V.', 'Hologic Inc.', 'Agilent Technologies Inc.', 'Sysmex Corporation', 'Illumina Inc.', 'PerkinElmer Inc.', 'Exact Sciences Corporation', 'Bio-Rad Laboratories Inc.', 'Myriad Genetics Inc.', 'Natera Inc.', 'Grifols S.A.', 'Quest Diagnostics Inc.', 'Laboratory Corporation of America Holdings (LabCorp)'.

Precision Diagnostics Market Size, Share, Growth Analysis, By Product Type (Consumables, Instruments), By Type (Genetic Tests, Direct to Consumer Tests), By Application (Oncology, Cardiology), By End-User (Hospitals, Diagnostic Laboratories), By Region - Industry Forecast 2025-2032

Report ID: SQMIG35G2102 | Region: Global | Published Date: January, 2025
Pages: 157 | Tables: 73 | Figures: 75

Precision Diagnostics Market News

In June 2021, Medical devices company, Trivitron Healthcare, introduced two new innovation-driven products for HbA1c and Hb variant detection. These products will be used for monitoring diabetes, hemoglobin variants, and thalassemia. The new product includes NANO H5 & NANO H110, high-performance liquid chromatography analyzers, and is fully automated.
In October 2020, Diaceutics PLC announced the launch of DXRX – The Diagnostic Network designed to increase the end-to-end development of precision medicine diagnostics by decreasing the time to peak biomarker test adoption for cancer testing from years to months.

Precision Diagnostics Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Precision Diagnostics Market size was valued at USD 68.07 billion in 2023 and is poised to grow from USD 80.59 billion in 2024 to USD 311.26 billion by 2032, growing at a CAGR of 18.4% during the forecast period (2025-2032).

New product launches, partnerships and investing in research & development have been a key business strategy for market. The global precision diagnostics market is fairly concentrated, with a few big and medium-sized market participants accounting for a large portion of market revenue. 'Roche (Switzerland) ', 'GE Healthcare (United States) ', 'Abbott Laboratories (United States) ', 'Philips Healthcare (Netherlands) ', 'Danaher Corporation (United States) ', 'Quest Diagnostics (United States) ', 'Fujifilm Medical (Japan) ', 'Becton, Dickinson and Company (United States) ', 'Siemens Healthineers (Germany) ', 'Hologic Inc. (United States) ', 'QIAGEN (Germany) ', 'Grifols (Spain) ', 'Beckman Coulter (United States) ', 'bioMerieux (France) ', 'Thermo Fisher Scientific (United States) ', 'PerkinElmer (United States) ', 'Illumina (United States) ', 'Agilent Technologies (United States) ', 'Bio-Rad Laboratories (United States) ', 'Merck Group (Germany)'

Personalised therapy has become well-known in recent years that genetic testing and genome sequencing are two of the most important tools used to understand the molecular basis of disease. Many genetic disorders are screened for in European countries, as early detection of these diseases can prevent the onset of symptoms or reduce the severity of the disease.

Rise in Prevalence of Cancer: The prevalence of cancer has grown globally. Concurrently, developments in cancer diagnosis, prevention, and treatment have increased. With advancements in precision diagnostics and therapies, as well as game-changing innovations such as Next Generation Sequencing (NGS) and big genomic data, the market is expected to grow progressively over the forecast period.

The presence of a large number of leading pharmaceutical and biotech companies, as well as well-established healthcare infrastructure, North America and Europe account for the largest share of the global market. Furthermore, government support, combined with increased R&D investment, is propelling these regional markets. For instance, the then-U.S. government announced the Precision Medicine Initiative in 2015 in order to improve research and development in this field.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Precision Diagnostics Market Size, Share, Growth Analysis, By Product Type (Consumables, Instruments), By Type (Genetic Tests, Direct to Consumer Tests), By Application (Oncology, Cardiology), By End-User (Hospitals, Diagnostic Laboratories), By Region - Industry Forecast 2025-2032

Precision Diagnostics Market News

Precision Diagnostics Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Precision Diagnostics Market?

Who are the key vendors in the Precision Diagnostics Market?

What is the key driver of Precision Diagnostics Market?

What is the key market trend for Precision Diagnostics Market?

Which region accounted for the largest share in Precision Diagnostics Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300